The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease.
about
Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapyPim1 inhibition as a novel therapeutic strategy for Alzheimer's diseaseSLC9A9 Co-expression modules in autism-associated brain regions.Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice.iPSC-derived familial Alzheimer's PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling.
P2860
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The mammalian target of rapamy ...... aging and Alzheimer's disease.
@ast
The mammalian target of rapamy ...... aging and Alzheimer's disease.
@en
type
label
The mammalian target of rapamy ...... aging and Alzheimer's disease.
@ast
The mammalian target of rapamy ...... aging and Alzheimer's disease.
@en
prefLabel
The mammalian target of rapamy ...... aging and Alzheimer's disease.
@ast
The mammalian target of rapamy ...... aging and Alzheimer's disease.
@en
P2093
P2860
P356
P1476
The mammalian target of rapamy ...... aging and Alzheimer's disease.
@en
P2093
Joshua S Talboom
Ramon Velazquez
Salvatore Oddo
P2860
P2888
P356
10.1038/NPJAMD.2015.8
P577
2015-10-15T00:00:00Z
P5875
P6179
1027139297